These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 7654141)
1. In vitro metabolism of cyclosporin A with rabbit renal or hepatic microsomes: analysis by HPLC-FPIA and HPLC-MS. Pham-Huy C; Sadeg N; Becue T; Martin C; Mahuzier G; Warnet JM; Hamon M; Claude JR Arch Toxicol; 1995; 69(5):346-9. PubMed ID: 7654141 [TBL] [Abstract][Full Text] [Related]
2. The dose-dependent inhibition of rat renal translation elongation seen after in vivo cyclosporin A is not caused by cyclosporin metabolites. Buss WC; Bowers LD Toxicology; 1995 Jun; 100(1-3):17-25. PubMed ID: 7624874 [TBL] [Abstract][Full Text] [Related]
3. Semipreparative chromatographic separation of cyclosporin G metabolites generated by microsomes from rabbits treated with rifampicin. Liu WT; Tamolang MB; Pang H; Ren Y; Wong PY J Pharmacol Toxicol Methods; 1996 Jun; 35(3):121-9. PubMed ID: 8782089 [TBL] [Abstract][Full Text] [Related]
4. Characterization of rat cytochrome P450 isozymes involved in the covalent binding of cyclosporin A to microsomal proteins. Sadrieh N; Thomas PE Toxicol Appl Pharmacol; 1994 Aug; 127(2):222-32. PubMed ID: 8048065 [TBL] [Abstract][Full Text] [Related]
5. A rifampicin-induced hepatic microsomal enzyme system for the generation of cyclosporine metabolites. Tamolang MB; Liu WT; Pang H; Ren Y; Wong PY Pharmacol Res; 1995 Sep; 32(3):141-8. PubMed ID: 8745344 [TBL] [Abstract][Full Text] [Related]
6. Metabolism of cyclosporin A. II. Implication of the macrolide antibiotic inducible cytochrome P-450 3c from rabbit liver microsomes. Bertault-Peres P; Bonfils C; Fabre G; Just S; Cano JP; Maurel P Drug Metab Dispos; 1987; 15(3):391-8. PubMed ID: 2886317 [TBL] [Abstract][Full Text] [Related]
7. Effect of cyclosporin A and its metabolites and analogs on lipid peroxidation in rabbit renal microsomes. Sadeg N; Pham Huy C; Martin C; Warnet JM; Claude JR Drug Chem Toxicol; 1993; 16(2):165-74. PubMed ID: 8486097 [TBL] [Abstract][Full Text] [Related]
8. The determination of metabolite M17 and its meaning for immunosuppressive cyclosporin therapy. Khoschsorur G; Auer T; Lanzer G; Petritsch P; Holzer H; Tscheliessnigg KH Angiology; 1998 Apr; 49(4):307-14. PubMed ID: 9555934 [TBL] [Abstract][Full Text] [Related]
9. Cyclosporin metabolism by human gastrointestinal mucosal microsomes. Webber IR; Peters WH; Back DJ Br J Clin Pharmacol; 1992 Jun; 33(6):661-4. PubMed ID: 1389941 [TBL] [Abstract][Full Text] [Related]
10. Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability. Lampen A; Christians U; Guengerich FP; Watkins PB; Kolars JC; Bader A; Gonschior AK; Dralle H; Hackbarth I; Sewing KF Drug Metab Dispos; 1995 Dec; 23(12):1315-24. PubMed ID: 8689938 [TBL] [Abstract][Full Text] [Related]
11. Metabolism of the cytochrome P450 mechanism-based inhibitor N-benzyl-1-aminobenzotriazole to products that covalently bind with protein in guinea pig liver and lung microsomes: comparative study with 1-aminobenzotriazole. Woodcroft KJ; Webb CD; Yao M; Weedon AC; Bend JR Chem Res Toxicol; 1997 May; 10(5):589-99. PubMed ID: 9168258 [TBL] [Abstract][Full Text] [Related]
12. Sites of biotransformation for the cyclosporin derivative SDZ IMM 125 using human liver and kidney slices and intestine. Comparison with rat liver slices and cyclosporin A metabolism. Vickers AE; Fisher RL; Brendel K; Guertler J; Dannecker R; Keller B; Fischer V Drug Metab Dispos; 1995 Mar; 23(3):327-33. PubMed ID: 7628297 [TBL] [Abstract][Full Text] [Related]
13. The effect of the new immunosuppressive drug FK506 on the formation of secondary metabolites of cyclosporin A. Bauer S; Brockmöller J; Kewitz H; Roots I Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):540-2. PubMed ID: 1283385 [TBL] [Abstract][Full Text] [Related]
14. Metabolism of cyclosporin A. III. Interaction of the macrolide antibiotic, erythromycin, using rabbit hepatocytes and microsomal fractions. Fabre I; Fabre G; Maurel P; Bertault-Peres P; Cano JP Drug Metab Dispos; 1988; 16(2):296-301. PubMed ID: 2898350 [TBL] [Abstract][Full Text] [Related]
15. Cyclosporin A metabolism in human liver, kidney, and intestine slices. Comparison to rat and dog slices and human cell lines. Vickers AE; Fischer V; Connors S; Fisher RL; Baldeck JP; Maurer G; Brendel K Drug Metab Dispos; 1992; 20(6):802-9. PubMed ID: 1362930 [TBL] [Abstract][Full Text] [Related]
16. Species differences in the hepatic and intestinal metabolism of cyclosporine. Whalen RD; Tata PN; Burckart GJ; Venkataramanan R Xenobiotica; 1999 Jan; 29(1):3-9. PubMed ID: 10078836 [TBL] [Abstract][Full Text] [Related]
17. Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes. Pichard L; Fabre I; Fabre G; Domergue J; Saint Aubert B; Mourad G; Maurel P Drug Metab Dispos; 1990; 18(5):595-606. PubMed ID: 1981707 [TBL] [Abstract][Full Text] [Related]
18. In vitro metabolism of alisol A and its metabolites' identification using high-performance liquid chromatography-mass spectrometry. Yu Y; Liu Z; Ju P; Zhang Y; Zhang L; Bi K; Chen X J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 941():31-7. PubMed ID: 24184833 [TBL] [Abstract][Full Text] [Related]
19. Metabolism of tilmicosin by rabbit liver microsomes and hepatocytes. Montesissa C; Capolongo F; Santi A; Biancotto G; Dacasto M Vet J; 2004 Jan; 167(1):87-94. PubMed ID: 14623156 [TBL] [Abstract][Full Text] [Related]
20. A comparison of cyclosporine assays using sequential samples from selected transplant patients. LeGatt DF; Coates JE; Simpson AI; Shalapay CE; Rintoul BJ; Yatscoff RW Clin Biochem; 1994 Feb; 27(1):43-8. PubMed ID: 8200114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]